Mobilizing the immune system may be a promising strategy to fight Alzheimer disease. A clinical trial has shed light on the therapeutic potential—and the pitfalls—of Aβ immunization.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Lleo, A., Greenberg, S.M. & Growdon, J.H. Annu. Rev. Med. 57, 513–533 (2006).
Schenk, D. et al. Nature 400, 173–177 (1999).
Gilman, S. et al. Neurology 64, 1553–1562 (2005).
Bacskai, B.J. et al. Nat. Med. 7, 369–372 (2001).
Bard, F. et al. Nat. Med. 6, 916–919 (2000).
Fox, N.C. et al. Neurology 64, 1563–1572 (2005).
Nicoll, J.A. et al. Nat. Med. 9, 448–452 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hyman, B., Growdon, J. Can the immune system fight Alzheimer disease?. Nat Med 12, 755–756 (2006). https://doi.org/10.1038/nm0706-755
Issue Date:
DOI: https://doi.org/10.1038/nm0706-755
This article is cited by
-
Alzheimer 100 – highlights in the history of Alzheimer research
Journal of Neural Transmission (2006)